TR201719926A2 - Farmasöti̇k olarak kabul edi̇lebi̇li̇r li̇tyum tuzlari ve c vi̇tami̇ni̇ i̇çeren farmasöti̇k bi̇leşi̇mler - Google Patents
Farmasöti̇k olarak kabul edi̇lebi̇li̇r li̇tyum tuzlari ve c vi̇tami̇ni̇ i̇çeren farmasöti̇k bi̇leşi̇mler Download PDFInfo
- Publication number
- TR201719926A2 TR201719926A2 TR2017/19926A TR201719926A TR201719926A2 TR 201719926 A2 TR201719926 A2 TR 201719926A2 TR 2017/19926 A TR2017/19926 A TR 2017/19926A TR 201719926 A TR201719926 A TR 201719926A TR 201719926 A2 TR201719926 A2 TR 201719926A2
- Authority
- TR
- Turkey
- Prior art keywords
- vitamin
- pharmaceutical compositions
- compositions containing
- pharmaceutically acceptable
- lithium salts
- Prior art date
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229910003002 lithium salt Inorganic materials 0.000 title 1
- 159000000002 lithium salts Chemical class 0.000 title 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 229910052744 lithium Inorganic materials 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Buluş lityum ve C vitaminini tek doz içerisinde birlikte içeren farmasötik kompozisyonlar ve bu kompozisyonların psikiyatrik hastalıklardan özellikle bipolar bozuklukların tedavisinde kullanımı ile ilgilidir.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/19926A TR201719926A2 (tr) | 2017-12-08 | 2017-12-08 | Farmasöti̇k olarak kabul edi̇lebi̇li̇r li̇tyum tuzlari ve c vi̇tami̇ni̇ i̇çeren farmasöti̇k bi̇leşi̇mler |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/19926A TR201719926A2 (tr) | 2017-12-08 | 2017-12-08 | Farmasöti̇k olarak kabul edi̇lebi̇li̇r li̇tyum tuzlari ve c vi̇tami̇ni̇ i̇çeren farmasöti̇k bi̇leşi̇mler |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201719926A2 true TR201719926A2 (tr) | 2019-06-21 |
Family
ID=67952612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/19926A TR201719926A2 (tr) | 2017-12-08 | 2017-12-08 | Farmasöti̇k olarak kabul edi̇lebi̇li̇r li̇tyum tuzlari ve c vi̇tami̇ni̇ i̇çeren farmasöti̇k bi̇leşi̇mler |
Country Status (1)
| Country | Link |
|---|---|
| TR (1) | TR201719926A2 (tr) |
-
2017
- 2017-12-08 TR TR2017/19926A patent/TR201719926A2/tr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024010140A (es) | Nuevos metodos. | |
| CY1125488T1 (el) | Παραγωγα πυριδινης και θεραπευτικες χρησεις αυτων ως αναστολεις trpc6 | |
| MX2018013472A (es) | Tratamiento de combinacion de trastornos y enfermedades inflamatorios oculares. | |
| TW201613919A (en) | Inhibitors of Bruton's tyrosine kinase | |
| CL2019002240A1 (es) | Dendrímeros terapéuticos. | |
| MX378566B (es) | Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos. | |
| MX391392B (es) | ANILLOS 5-5 FUSIONADOS COMO INHIBIDORES C5a. | |
| MX2024002360A (es) | Uso de estimuladores de la guanilato ciclasa soluble (sgc) para el tratamiento de trastornos mitocondriales. | |
| JOP20210090A1 (ar) | مشتقات بيريدينيل سلفوناميد، تركيبات صيدلانية واستخداماتها | |
| MA39765A (fr) | Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation | |
| MX387731B (es) | Composiciones farmacéuticas orales de mesalazina. | |
| EA202091112A1 (ru) | Сокристаллы, фармацевтические композиции на их основе и способы лечения, предусматривающие их применение | |
| ECSP16086247A (es) | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
| PH12021550671A1 (en) | Prodrugs of cgrp antagonists | |
| EA201691796A1 (ru) | П-замещенные асимметричные мочевины и их применение в медицине | |
| MX2019005309A (es) | Anticuerpos anti-bag3 en combinacion con inhibidores del punto de control inmunitario para uso terapeutico. | |
| MX2018014129A (es) | Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato. | |
| UY35890A (es) | Uso de laquinimod para retrasar la progresión de la enfermedad de huntington | |
| CY1119522T1 (el) | (r)- πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη | |
| ZA201906153B (en) | Pharmaceutical compositions for combination therapy | |
| TR201717703A2 (tr) | Api̇ksaban formülasyonlari | |
| TR201719926A2 (tr) | Farmasöti̇k olarak kabul edi̇lebi̇li̇r li̇tyum tuzlari ve c vi̇tami̇ni̇ i̇çeren farmasöti̇k bi̇leşi̇mler | |
| TW201613926A (en) | Inhibitors of bruton's tyrosine kinase | |
| MX384394B (es) | Compuesto para uso en la prevención y tratamiento de enfermedades neurodegenerativas. | |
| EA202190247A1 (ru) | ПРИМЕНЕНИЕ рГЦ СТИМУЛЯТОРОВ ДЛЯ ЛЕЧЕНИЯ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ |